MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.
Molina E, García-Gutiérrez L, Junco V, Perez-Olivares M, de Yébenes VG, Blanco R, Quevedo L, Acosta JC, Marín AV, Ulgiati D, Merino R, Delgado MD, Varela I, Regueiro JR, Moreno de Alborán I, Ramiro AR, León J.
Molina E, et al. Among authors: de yebenes vg.
Oncogene. 2023 Nov;42(45):3358-3370. doi: 10.1038/s41388-023-02846-9. Epub 2023 Sep 29.
Oncogene. 2023.
PMID: 37773203